Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone re...
Q2 2026
Aug 5, 2026
Q1 2026
May 6, 2026
FY 2025
Feb 19, 2026
Q4 2025
Q3 2025
Nov 4, 2025
